Brief: Nymox files for marketing approval for fexapotide triflutate in Europe
03/05/2017 14:30
May 3 (Reuters) - Nymox Pharmaceutical Corp NYMX.O :
* Nymox files for marketing approval for fexapotide
triflutate in Europe
Source text for Eikon: ID:nGNXNUPZPa
Further company coverage: NYMX.O
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba